Results 11 to 20 of about 72,294 (253)

CDK-1 Inhibition in G2 Stabilizes Kinetochore-Microtubules in the following Mitosis. [PDF]

open access: yesPLoS ONE, 2016
Cell proliferation is driven by cyclical activation of cyclin-dependent kinases (CDKs), which produce distinct biochemical cell cycle phases. Mitosis (M phase) is orchestrated by CDK-1, complexed with mitotic cyclins.
A Sophia Gayek, Ryoma Ohi
doaj   +2 more sources

CDK control pathways integrate cell size and ploidy information to control cell division [PDF]

open access: yeseLife, 2021
Maintenance of cell size homeostasis is a property that is conserved throughout eukaryotes. Cell size homeostasis is brought about by the co-ordination of cell division with cell growth and requires restriction of smaller cells from undergoing mitosis ...
James Oliver Patterson   +3 more
doaj   +3 more sources

An RB insensitive to CDK regulation

open access: yesMolecular & Cellular Oncology, 2017
The N-term phosphorylation of Retinoblastoma (RB) by the p38 stress-activated protein kinase (SAPK) makes RB insensitive to cyclin-dependent kinase (CDK)-Cyclin inhibition, which enhances the transcriptional repression of E2F-driven promoters and delays ...
Manel Joaquin   +2 more
doaj   +2 more sources

Cyclins and Cyclin‐Dependent Kinases: Structure, Biological Functions, and Innovative Targeting Strategies in Cancer [PDF]

open access: yesMedComm
Cyclins and cyclin‐dependent kinases (CDKs) are frequently dysregulated in human cancers and represent compelling therapeutic targets. Beyond their well‐recognized roles in cell cycle control, CDK/cyclin complexes orchestrate diverse oncogenic processes,
Suya Zheng   +9 more
doaj   +2 more sources

Cyclin-dependent kinase-inhibitor screening and structural analysis identify a CDK-like kinase candidate in Naegleria fowleri [PDF]

open access: yesParasites & Vectors
Background Primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri is a highly fatal central nervous system infection for which effective treatment options remain limited. This study explored CDK-related pathways in N.
Min-Jeong Kim, Joo Hwan No
doaj   +2 more sources

Idiopathic Congenital Dislocation of the Knee: Case Series of Spontaneous Reduction [PDF]

open access: yesJournal of Orthopaedic Case Reports
Introduction: Idiopathic congenital dislocation of the knee (CDK) represents a distinct clinical category. Grade III CDK, defined as knee flexion
Nabil Alassaf
doaj   +2 more sources

Dynamic regulation of origin firing factors links CDK activity to dormant origin activation [PDF]

open access: yesNature Communications
Eukaryotic cells license far more potential replication origins than they use, but how origin firing rate is tuned in S phase, especially under replication stress, remains unclear. Here, we identify a regulatory mechanism by which cyclin-dependent kinase
Md Shahadat Hossain   +5 more
doaj   +2 more sources

Customer Appointment Analysis in Automobile Dealerships

open access: yesProceedings of the International Florida Artificial Intelligence Research Society Conference, 2022
Appointment scheduling prior to in-person visit to vehicle service centers is a well-known activity in our daily lives; we often do that to save our- selves time during our visits.
Priya Saha   +2 more
doaj   +1 more source

A Journey through Time on the Discovery of Cell Cycle Regulation

open access: yesCells, 2022
All living organisms on Earth are made up of cells, which are the functional unit of life. Eukaryotic organisms can consist of a single cell (unicellular) or a group of either identical or different cells (multicellular).
Rustem Uzbekov, Claude Prigent
doaj   +1 more source

CDK1/2/5 blockade: killing two birds with one stone

open access: yesOncoImmunology, 2021
Pancreatic ductal adenocarcinoma (PDAC) is an immune resistant tumor. We recently demonstrated that inhibiting CDK1/2/5 by dinaciclib not only blocks immune checkpoint expression, but also triggers histone-dependent immunogenic cell death.
Jiao Liu, Rui Kang, Daolin Tang
doaj   +1 more source

Home - About - Disclaimer - Privacy